Clinical trial
Peripheral Retinal Cryoapplication Versus Anti-VEGF Intravitreal Injection Before Vitrectomy for Complicated Proliferative Diabetic Retinopathy
NCT05514925 is registered in ClinicalTrials.gov with Khairallah Moncef as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Peripheral Retinal Cryoapplication Versus Anti-VEGF Intravitreal Injection Before Vitrectomy for Complicated Proliferative Diabetic Retinopathy
- Lead sponsor
- Khairallah Moncef
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- November 21, 2017
- Completion date
- December 31, 2022
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
proliferative diabetic retinopathy, tractional retinal detachment, vitreous hemorrhage